secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001558370-24-008310
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Capricor shareholders approve doubling authorized shares to 100M and elect all nine director nominees
--------------------------------------------------------------------------------

- Amendment to increase authorized common shares from 50M to 100M approved (12.3M for, 8.7M against).
- All nine director nominees elected, including CEO Linda Marbán and Frank Litvack.
- Ratification of Rose, Snyder & Jacobs as auditor for FY 2024 approved (20.3M for).
- Non-binding advisory vote on executive compensation approved (9.2M for, 2.0M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/capr-20240514x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer